Your browser doesn't support javascript.
loading
DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras.
Zhang, Xiaoyu; Luukkonen, Lena M; Eissler, Christie L; Crowley, Vincent M; Yamashita, Yu; Schafroth, Michael A; Kikuchi, Shota; Weinstein, David S; Symons, Kent T; Nordin, Brian E; Rodriguez, Joe L; Wucherpfennig, Thomas G; Bauer, Ludwig G; Dix, Melissa M; Stamos, Dean; Kinsella, Todd M; Simon, Gabriel M; Baltgalvis, Kristen A; Cravatt, Benjamin F.
Afiliación
  • Zhang X; The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
  • Luukkonen LM; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Eissler CL; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Crowley VM; The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
  • Yamashita Y; The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
  • Schafroth MA; Medicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., 463-10 Kawauchi-cho, Tokushima, 771-0192, Japan.
  • Kikuchi S; The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
  • Weinstein DS; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Symons KT; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Nordin BE; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Rodriguez JL; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Wucherpfennig TG; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Bauer LG; The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
  • Dix MM; The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
  • Stamos D; The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.
  • Kinsella TM; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Simon GM; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Baltgalvis KA; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
  • Cravatt BF; Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.
J Am Chem Soc ; 143(13): 5141-5149, 2021 04 07.
Article en En | MEDLINE | ID: mdl-33783207
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complejos de Ubiquitina-Proteína Ligasa Límite: Humans / Male Idioma: En Revista: J Am Chem Soc Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complejos de Ubiquitina-Proteína Ligasa Límite: Humans / Male Idioma: En Revista: J Am Chem Soc Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos